Electron microscopy of an α-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus

Virology

Volumn 325, Issue 2, 2004, Pages 207-215

  Kunz, Stefan ^a   Calder, Lesley ^b   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Dystroglycan; Electron microscopy; Laminin

Indexed keywords

ALPHA DYSTROGLYCAN; DYSTROGLYCAN; FC RECEPTOR; LAMININ; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARENAVIRUS; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CYTOSKELETAL PROTEINS; DNA PRIMERS; DYSTROGLYCANS; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; RABBITS; RECEPTORS, LAMININ; RECEPTORS, VIRUS;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 3142530537     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.044     Document Type: Article

References (25)

1. Ahmed R., Salmi A., Butler L.D., Chiller J.M., Oldstone M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:1984;521-540
2. Andac Z., Sasaki T., Mann K., Brancaccio A., Deutzmann R., Timpl R. Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alpha1 chain by site-directed mutagenesis. J. Mol. Biol. 287:1999;253-264
3. Borrow P., Oldstone M.B. Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J. Virol. 66:1992;7270-7281
4. Buchmeier M.J., Lewicki H.A., Tomori O., Oldstone M.B. Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology. 113:1981;73-85
5. Burton D.R., Saphire E.O., Parren P.W. A model for neutralization of viruses based on antibody coating of the virion surface. Curr. Top. Microbiol. Immunol. 260:2001;109-143
6. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B.A. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 282:1998;2079-2081
7. Chen Y., Maguire T., Marks R.M. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol. 70:1996;8765-8772
8. Dutko F.J., Oldstone M.B. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1983;1689-1698
9. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1991;1121-1131
10. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:1993;809-823
11. Gee S.H., Blacher R.W., Douville P.J., Provost P.R., Yurchenco P.D., Carbonetto S. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J. Biol. Chem. 268:1993;14972-14980
12. Henry M.D., Campbell K.P. A role for dystroglycan in basement membrane assembly. Cell. 95:1998;859-870
13. Henry M.D., Satz J.S., Brakebusch C., Costell M., Gustafsson E., Fassler R., Campbell K.P. Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 114:2001;1137-1144
14. Hohenester E., Tisi D., Talts J.F., Timpl R. The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin. Mol. Cell. 4:1999;783-792
15. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702
16. Kanagawa M., Saito F., Kunz S., Yoshida-Moriguchi T., Barresi R., Kobayashi Y.M., Muschler J., Dumanski J.P., Michele D.E., Oldstone M.B., Campbell K.P. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell available on-line. 2004
17. Kunz S., Sevilla N., McGavern D., Campbell K.P., Oldstone M.B.A. Molecular analysis of the interaction of LCMV with its cellular receptor alpha-dystroglycan. J. Cell Biol. 155:2001;301-310
18. Kunz S., Campbell K.P., Oldstone M.B.A. Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan. Virology. 2003;. (in press)
19. Kunz S., Edelmann K.H., de la Torre J.C., Gorney R., Oldstone M.B.A. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology. 314:2003;168-178
20. McCormick J.B., Fisher-Hoch S.P. Lassa fever. Curr. Top. Microbiol. Immunol. 262:2002;75-109
21. Pall E.A., Bolton K.M., Ervasti J.M. Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins. J. Biol. Chem. 271:1996;3817-3821
22. Parren P.W., Burton D.R. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77:2001;195-262
23. Peters C.J., Jahrling P., Liu C.T., Kenyon K.T., McKee K.T., Barrera-Oro J.G. Experimental studies of arenaviral hemorrhagic fevers. Curr. Top. Microbiol. Immunol. 134:1987;5-68
24. Spiropoulou C.F., Kunz S., Rollin P.E., Campbell K.P., Oldstone M.B.A. New world arenavirus clade C, but not clade A and B viruses, utilize alpha-dystroglycan as its major receptor. J. Virol. 76:2002;5140-5146
25. Talts J.F., Andac Z., Gohring W., Brancaccio A., Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 18:1999;863-870